DAR

In the past six months, Darling Ingredients' stock experienced several notable events: on April 30, 2026, the company reported a significant turnaround in Q1 2026 earnings, moving to a net income of $134.3 million ($0.83 per diluted share) from a net loss in Q1 2025, which led to a 4.1% gain in DAR shares. An Annual General Meeting was held on May 7, 2026. On June 3, 2026, a U.S. patent was granted for Nextida® GC, a collagen peptide ingredient for blood sugar support under its Rousselot brand. On July 30, 2026, Darling Ingredients reported strong Q2 2026 earnings, with net income of $387.3 million ($2.41 per diluted share), largely driven by the Diamond Green Diesel joint venture, surpassing analyst expectations. On August 5, 2026, the Board of Directors authorized a $1.0 billion share repurchase program. The company announced an agreement to sell approximately $150 million of production tax credits on August 11, 2026. On September 22, 2026, UBS raised its price target on Darling Ingredients to $88 from $78, maintaining a Buy rating. Despite strong performance, executives, including CEO Randall Stuewe, have engaged in significant insider selling, with nineteen transactions totaling over five million dollars in sales versus sixty thousand in buys over ninety days.